Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$291M Buy
828,097
+44,394
+6% +$15.8M 0.12% 157
2025
Q4
$257M Sell
783,703
-23,852
-3% -$7.57M 0.11% 159
2025
Q3
$228M Sell
807,555
-101,787
-11% -$29.5M 0.1% 192
2025
Q2
$254M Buy
909,342
+25,984
+3% +$7.36M 0.12% 161
2025
Q1
$275M Buy
883,358
+187,524
+27% +$55.4M 0.14% 132
2024
Q4
$181M Sell
695,834
-63,415
-8% -$18.8M 0.11% 172
2024
Q3
$245M Sell
759,249
-29,260
-4% -$9.57M 0.14% 131
2024
Q2
$246M Buy
788,509
+101,572
+15% +$29.8M 0.16% 123
2024
Q1
$195M Buy
686,937
+82,006
+14% +$24M 0.13% 146
2023
Q4
$174M Sell
604,931
-9,750
-2% -$2.66M 0.12% 145
2023
Q3
$165M Sell
614,681
-52,822
-8% -$13.2M 0.12% 131
2023
Q2
$148M Buy
667,503
+94,690
+17% +$22M 0.1% 158
2023
Q1
$138M Sell
572,813
-107,720
-16% -$26.4M 0.1% 164
2022
Q4
$179M Buy
680,533
+123,263
+22% +$33M 0.14% 124
2022
Q3
$126M Buy
557,270
+37,226
+7% +$9.02M 0.09% 173
2022
Q2
$127M Sell
520,044
-110,413
-18% -$27.1M 0.09% 178
2022
Q1
$152M Sell
630,457
-573,846
-48% -$132M 0.09% 185
2021
Q4
$271M Buy
1,204,303
+104,738
+10% +$22.1M 0.15% 117
2021
Q3
$234M Sell
1,099,565
-16,662
-1% -$3.84M 0.14% 125
2021
Q2
$272M Sell
1,116,227
-170,431
-13% -$41.9M 0.16% 115
2021
Q1
$320M Buy
1,286,658
+108,326
+9% +$25.8M 0.21% 89
2020
Q4
$271M Buy
1,178,332
+103,128
+10% +$23.8M 0.16% 109
2020
Q3
$273M Buy
1,075,204
+156,511
+17% +$38.8M 0.18% 87
2020
Q2
$217M Buy
918,693
+135,070
+17% +$30.8M 0.17% 98
2020
Q1
$159M Sell
783,623
-54,213
-6% -$11.8M 0.14% 112
2019
Q4
$202M Sell
837,836
-53,453
-6% -$11.8M 0.15% 123
2019
Q3
$172M Sell
891,289
-93,093
-9% -$17.9M 0.14% 133
2019
Q2
$181M Buy
984,382
+312,162
+46% +$55.9M 0.15% 121
2019
Q1
$128M Sell
672,220
-313,307
-32% -$59.8M 0.12% 142
2018
Q4
$192M Buy
985,527
+75,218
+8% +$14.7M 0.19% 78
2018
Q3
$189M Buy
910,309
+183,957
+25% +$36.3M 0.17% 98
2018
Q2
$134M Sell
726,352
-280,930
-28% -$49.7M 0.12% 130
2018
Q1
$172M Buy
1,007,282
+252,564
+33% +$46.4M 0.14% 108
2017
Q4
$131M Buy
754,718
+41,219
+6% +$7.29M 0.11% 174
2017
Q3
$133M Buy
713,499
+2,179
+0.3% +$386K 0.11% 142
2017
Q2
$123M Sell
711,320
-259,373
-27% -$42.2M 0.11% 129
2017
Q1
$159M Sell
970,693
-167,556
-15% -$27.8M 0.14% 89
2016
Q4
$166M Buy
1,138,249
+301,808
+36% +$45.4M 0.15% 102
2016
Q3
$140M Buy
836,441
+25,982
+3% +$4.39M 0.13% 116
2016
Q2
$123M Buy
810,459
+29,969
+4% +$4.66M 0.13% 130
2016
Q1
$117M Sell
780,490
-18,391
-2% -$2.73M 0.13% 130
2015
Q4
$130M Sell
798,881
-107,316
-12% -$16.9M 0.13% 127
2015
Q3
$125M Sell
906,197
-247,191
-21% -$39M 0.12% 130
2015
Q2
$177M Sell
1,153,388
-6,051
-0.5% -$969K 0.16% 95
2015
Q1
$185M Buy
1,159,439
+101,721
+10% +$16M 0.18% 84
2014
Q4
$168M Buy
1,057,718
+154,477
+17% +$24.1M 0.15% 109
2014
Q3
$127M Buy
903,241
+26,426
+3% +$3.45M 0.11% 153
2014
Q2
$104M Buy
876,815
+75,700
+9% +$8.76M 0.1% 181
2014
Q1
$98.8M Sell
801,115
-97,253
-11% -$11.8M 0.1% 156
2013
Q4
$103M Sell
898,368
-37,457
-4% -$4.26M 0.09% 187
2013
Q3
$105M Sell
935,825
-129,258
-12% -$14M 0.1% 173
2013
Q2
$105M Buy
+1,065,083
New +$111M 0.1% 141

Other funds holding AMGN

Citigroup's AMGN Position: Q1 2026 in Review

Citigroup increased its Amgen (AMGN) stake by 5.7% in Q1 2026, buying an estimated $15.8M and bringing the position to 828,097 shares worth $291M. The position accounts for 0.12% of the portfolio, ranked #157.

Citigroup first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $320M in Q1 2021. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Citigroup held 828,097 shares of Amgen worth $291M as of Q1 2026.
  • Citigroup bought 44,394 Amgen shares in Q1 2026, an estimated $15.8M.
  • Amgen made up 0.12% of Citigroup's portfolio in Q1 2026, its #157 holding.
  • Citigroup first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Amgen position peaked at $320M in Q1 2021.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.